JATT II Acquisition Corp. focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses in healthcare and healthcare-related businesses. The company was incorporated in 2026 and is based in Westfield, New Jersey.
JATT III Acquisition Corp Announces Closing of $69,000,000 Initial Public Offering
JATT III Acquisition Corp closed its initial public offering of 6.9 million ordinary shares at $10.00 per share, generating $69 million in gross proceeds.
The offering included the full exercise of the underwriters' over-allotment option, with Guggenheim Securities serving as the sole book-running manager.
The blank check company intends to target healthcare and life sciences businesses, focusing specifically on those applying data-driven approaches like machine learning and computational biology.